MTCRMetacrine Inc

$0.00
$0.00
(0.00%)
Today
Updated:
Mkt Cap$24.75M
Vol83,889.00
63

Bullish Sentiment

How do you feel about MTCR?

About

Metacrine, Inc. is a clinical-stage biopharmaceutical company, which engages in the discovery and development of therapies for patients with liver and gastrointestinal (GI) diseases. It offers farnesoid X receptor (FXR), which is central to modulating liver and GI diseases. The company was founded by Ronald M. Evans, Richard A. Heyman, and Michael Downes in 2014 and is headquartered in San Diego, CA.
Sector:
Health Technology
Industry:
Pharmaceuticals Major
Employees:
N/A

Frequently Asked Questions

What is Market Cap of Metacrine Inc?
What is the 52-week high for Metacrine Inc?
What is the 52-week low for Metacrine Inc?
What is Metacrine Inc stock price today?
What was Metacrine Inc stock price yesterday?
What is the PE ratio of Metacrine Inc?
What is the Price-to-Book ratio of Metacrine Inc?
What is the 50-day moving average of Metacrine Inc?

Latest MTCR News

View

Advertisement|Remove ads.

Advertisement|Remove ads.